-+ 0.00%
-+ 0.00%
-+ 0.00%
Tandem Diabetes Care Wins Health Canada Approval for Expanded Insulin Pump Use
Share
Listen to the news
Tandem Diabetes Care Wins Health Canada Approval for Expanded Insulin Pump Use
  • Health Canada approved expanded use of Tandem Diabetes Care's t:slim X2 insulin pump with Control-IQ+ technology.
  • The approval covers type 1 diabetes during pregnancy, adults with type 2 diabetes and compatibility with Abbott's FreeStyle Libre 3 Plus Sensor.
  • Sensor compatibility and expanded indications are expected to become available in the second quarter of 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tandem Diabetes Care Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261112868686) on November 12, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending